DEEPNOID INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,030 KRW | -4.40% |
|
-8.23% | -25.48% |
| 2023 | DeepNoid to Raise 17.9 Billion Won via Stock Offering | MT |
| 2023 | DEEPNOID Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| Sales 2022 | 3.18B 2.33M | Sales 2023 | 1.93B 1.42M | Capitalization | 238B 175M |
|---|---|---|---|---|---|
| Net income 2022 | -5.33B -3.9M | Net income 2023 | -6.74B -4.93M | EV / Sales 2022 | 13.4 x |
| Net cash position 2022 | 10.21B 7.47M | Net cash position 2023 | 28.5B 20.86M | EV / Sales 2023 | 109 x |
| P/E ratio 2022 |
-4.95
x | P/E ratio 2023 |
-15.4
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.29% |
More Fundamentals
* Assessed data
| 1 day | -4.40% | ||
| 1 week | -8.23% | ||
| Current month | +2.82% | ||
| 1 month | +5.52% | ||
| 3 months | -14.26% | ||
| 6 months | -29.41% | ||
| Current year | -25.48% |
1 week
7 980.00
8 960.00
1 month
7 030.009 130.00
Current year
7 000.0012 375.00
1 year
4 500.0016 475.00
3 years
2 620.0019 500.00
5 years
2 620.0019 500.00
10 years
2 620.0019 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Woo-Sik Choi
CEO | Chief Executive Officer | 55 | 07-12-31 |
Jong-Chae Jung
DFI | Director of Finance/CFO | 51 | 17-12-31 |
Tae-Kyu Kim
CTO | Chief Tech/Sci/R&D Officer | 50 | 07-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Seok-Cheol Jeon
BRD | Director/Board Member | 41 | - |
Woo-Sik Choi
CEO | Chief Executive Officer | 55 | 07-12-31 |
Jong-Chae Jung
DFI | Director of Finance/CFO | 51 | 17-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-23 | 8,030 | -4.40% | 184 474 |
| 24-05-23 | 8,400 | -1.87% | 213,940 |
| 24-05-22 | 8,560 | -1.50% | 260,912 |
| 24-05-21 | 8,690 | +0.12% | 254,848 |
| 24-05-20 | 8,680 | -1.92% | 397,409 |
End-of-day quote Korea S.E., May 23, 2024
More quotes
Deep Noid Inc is a Korea-based company principally engaged in the medical artificial intelligence (AI) solutions. The Company a virtuous cycle of medical AI ecosystem based on a continuous and integrated all-in-one medical AI platform for accurate and efficient research and an AI clinical decision support system for actual clinical application. The Company's main products include DEEP:AI, DEEP:PHI, DEEP:STORE, and DEEP:PACS.
Sector
IT Services & Consulting
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -25.48% | 138M | |
| +10.14% | 3.71B | |
| -2.19% | 3.09B | |
| -35.77% | 1.58B | |
| -55.97% | 760M | |
| -29.51% | 585M | |
| -15.42% | 337M | |
| -30.48% | 298M | |
| -13.91% | 206M | |
| -6.48% | 192M |
- Stock Market
- Equities
- A315640 Stock
